Δ8-Tetrahydrocannabivarin prevents hepatic ischaemia/reperfusion injury by decreasing oxidative stress and inflammatory responses through cannabinoid CB2 receptors-Reference-Cited by-同舟云学术

Δ8-Tetrahydrocannabivarin prevents hepatic ischaemia/reperfusion injury by decreasing oxidative stress and inflammatory responses through cannabinoid CB2 receptors

Published:2012-03-23 Issue:8 Volume:165 Page:2450-2461
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:

Author:

Bátkai Sándor,Mukhopadhyay Partha,Horváth Bėla,Rajesh Mohanraj,Gao Rachel Y,Mahadevan Anu,Amere Mukkanti,Battista Natalia,Lichtman Aron H,Gauson Lisa A,Maccarrone Mauro,Pertwee Roger G,Pacher Pál

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1476-5381.2011.01410.x/fullpdf

Reference39 articles.

1. Guide to Receptors and Channels (GRAC), 5th Edition;Alexander;Br J Pharmacol,2011

2. Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury;Batkai;FASEB J,2007

3. The plant cannabinoid Δ9-tetrahydrocannabivarin can decrease signs of inflammation and inflammatory pain in mice;Bolognini;Br J Pharmacol,2010

4. Antagonism of the cannabinoid CB-1 receptor protects rat liver against ischaemia-reperfusion injury complicated by endotoxaemia;Caraceni;Gut,2009

5. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (IC50) of an enzymatic reaction;Cheng;Biochem Pharmacol,1973

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of Δ<sup>8</sup>-Tetrahydrocannabinol (THC) and Δ<sup>9</sup>-THC Analogs, with Different Lengths of Alkyl Chain at C-3 Position, in Oil Products Distributed on the Internet;YAKUGAKU ZASSHI;2024-08-01

2. Tetrahydrocannabivarin is Not Tetrahydrocannabinol;Cannabis and Cannabinoid Research;2024-07-12

3. LC–MS-MS quantification of Δ8-THC, Δ9-THC, THCV isomers and their main metabolites in human plasma;Journal of Analytical Toxicology;2024-06-05

4. Using In Silico Molecular Docking to Explain Differences in Receptor Binding Behavior of HHC and THCV Isomers: Revealing New Binding Modes;Pharmaceuticals;2024-05-15

5. The intervention of cannabinoid receptor in chronic and acute kidney disease animal models: a systematic review and meta-analysis;Diabetology & Metabolic Syndrome;2024-02-15